MedIntegrity Showcases Advanced Quality Control Solutions at INTERPEX 2026 in New York
MedIntegrity Showcases Advanced Quality Control Solutions at INTERPEX 2026 in New York
MedIntegrity, a leading global provider of precision analytical instruments for the biopharmaceutical and healthcare industries, has successfully concluded its participation in **INTERPEX 2026 New York International Biopharmaceutical Exhibition**. As a top-tier industry event in North America’s pharmaceutical production, R&D, and regulatory compliance sectors, this exhibition provided MedIntegrity with an efficient platform for demonstration and connection, enabling the brand to successfully engage in in-depth exchanges with global biopharmaceutical industry partners, explore new opportunities for industry development, and achieve fruitful results.
The exhibition was successfully held at the Jacob K. Javits Convention Center (Javits Center, New York, USA) from **April 21 to 23, 2026**. MedIntegrity was located at **Booth 1957**, where it showcased a full range of cutting-edge quality control equipment covering the entire process of biopharmaceutical production, R&D, and quality control. It provided one-stop compliant quality control solutions for industry partners, attracting numerous industry colleagues to stop for consultation and in-depth exchanges.
During the exhibition, MedIntegrity fully presented its diversified core product portfolio. Among them, the following three core products were featured as representative exhibits, focusing on demonstrating the brand’s technical strength and innovative achievements in the quality control field (a variety of other high-quality products were also displayed on site, receiving widespread attention):
1. **Filter Integrity Testers**: Fully automated testing systems that can accurately verify the integrity of sterilizing-grade filters. They support multiple testing methods such as bubble point, diffusion flow, pressure decay, and water intrusion, with efficient operation and precise results, suitable for various biopharmaceutical filter testing scenarios.
2. **Total Organic Carbon (TOC) Analyzers**: High-precision analytical instruments dedicated to the monitoring and compliance verification of organic contaminants in pharmaceutical water systems, purified water, injectable solutions, and other samples, helping enterprises meet stringent quality control standards.
3. **Packaging Seal Integrity Testers**: Advanced non-destructive testing solutions that can efficiently confirm the hermetic seal integrity of various primary pharmaceutical packaging such as vials, syringes, and blister packs, avoiding drug contamination, deterioration, and other issues caused by packaging leakage, and safeguarding product safety.
A senior spokesperson for MedIntegrity commented after the exhibition: “As a core platform connecting global biopharmaceutical industry leaders, INTERPEX allowed us to fully demonstrate the company’s innovative technologies and full range of quality control solutions. Our product portfolio not only includes the three types of equipment highlighted in this exhibition but also covers the entire scenario of biopharmaceutical quality control. All products strictly comply with stringent global standards such as USP (United States Pharmacopeia), EP (European Pharmacopeia), JP (Japanese Pharmacopeia), and FDA 21 CFR Part 11. This participation further confirms that our products and services can effectively help pharmaceutical enterprises simplify verification processes, reduce production risks, improve quality control efficiency, and protect patient medication safety.”
MedIntegrity achieved remarkable results in this exhibition. Booth 1957 was highly popular, and the on-site practical demonstrations of the full range of products and professional explanations by technical experts won high recognition and widespread attention from global biopharmaceutical industry colleagues and partners. The company’s products attracted significant attention from numerous customers, and following the conclusion of the exhibition, MedIntegrity arranged product demonstrations for interested clients to further showcase the performance and advantages of its equipment. During the period, the brand reached preliminary cooperation intentions with many potential customers, further expanded its global market layout, and deepened cooperative relations with existing partners. MedIntegrity’s products are widely used in pharmaceutical, biotechnology, medical device, and other fields. With stable performance, convenient operation, and strict compliance, they have long won the trust and recognition of numerous global industry customers, and this exhibition further enhanced the brand’s influence.
### About MedIntegrity
MedIntegrity is a trusted provider of analytical and quality control solutions for the global life sciences industry. Specializing in a full range of quality control instruments including filter integrity testing, total organic carbon analysis, and packaging seal verification, the company delivers reliable, user-friendly instrumentation that meets current Good Manufacturing Practice (cGMP) and international regulatory requirements. With a focus on innovation, accuracy, and operational efficiency, MedIntegrity empowers manufacturers to uphold the highest standards of product quality and compliance.
### About INTERPEX 2026
INTERPEX is a benchmark exhibition in the global pharmaceutical and biomanufacturing field. The 2026 exhibition gathered more than 600 exhibitors and over 10,000 industry professionals, and was successfully held at the Javits Center in New York from April 21 to 23. It showcased cutting-edge technologies and held professional technical forums, building a full-industry-chain exchange and cooperation platform for the global biopharmaceutical industry, and concluded successfully.
Italian 
English 
Russian 
Spanish 
Portuguese 
German 
French 
Arabic 
Dutch 
Japanese 
Vietnamese 
Korean 
Malay 
Thai 
